Home Newsfeeds Morgan Stanley Maintains Equal-Weight on Teleflex, Lowers Price Target to $278

Morgan Stanley Maintains Equal-Weight on Teleflex, Lowers Price Target to $278

Morgan Stanley analyst Drew Ranieri maintains Teleflex (NYSE:TFX) with a Equal-Weight and lowers the price target from $300 to $278.

byBenzinga Newsdesk

July 29, 2022

1 minute read

Morgan Stanley analyst Drew Ranieri maintains Teleflex (NYSE:TFX) with a Equal-Weight and lowers the price target from $300 to $278.

Acasti Pharma Q3 EPS $(0.09) Beats $(0.11) Estimate, Cash Balance Of $31.3M With Cash Runway Into Q2 Of 2024

By Benzinga Newsdesk

February 14, 8:04 AM

Acasti Pharma (NASDAQ:ACST) reported quarterly losses of $(0.09) per share which beat the analyst consensus estimate of $(0.11) by 18.18 percent. This is unchanged from the same period last year.

ACST

If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today

By Benzinga Insights

September 19, 10:55 AM

Twilio (NYSE:TWLO) has outperformed the market over the past 5 years by 10.04% on an annualized basis producing an average annual return of 19.13%. Currently, Twilio has a market capitalization of $13.55 billion.

TWLO